Literature DB >> 24284371

Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging.

Xiangyu Chen1, Enhua Xiao, Dianshuang Shu, Chengzhi Yang, Bin Liang, Zhong He, Dujun Bian.   

Abstract

PURPOSE: To compare the characteristics of magnetic resonance perfusion-weighted imaging (MRPWI) scans before and after transcatheter arterial chemoembolization (TACE) treatment of hepatocellular carcinoma (HCC) and to apply MRPWI in evaluating the therapeutic effect of TACE and prognosis of HCC.
MATERIALS AND METHODS: Thirty-five patients with HCC undergoing their first TACE treatment were enrolled in this study. T2WI, T1WI, and PWI of MRI were performed 24-48 h before TACE and 48-168 h after TACE. Perfusion parameters calculated with the maximum slope were used to create a time-signal intensity curve (TSC). The efficacy of TACE treatment in HCC was evaluated by examining the hemodynamic changes in TSC caused by TACE treatment.
RESULTS: TSC before TACE showed a pattern of a quick decrease and a slow increase in the tumor region of interest in 34 patients with HCC, whereas the TSC for normal liver tissues showed a pattern of slow decrease and slow increase. After TACE, the fluctuating range of TSC was significantly reduced in 31 patients, slightly reduced in three, and did not change significantly in one. The 3-year survival rate was 28.6%.
CONCLUSION: MRPWI of the liver does not only show the anatomy of HCC lesions but also reflects hemodynamic changes of HCC before and after TACE to a certain extent. It is very useful for clinical evaluation of the efficacy of TACE for HCC.

Entities:  

Mesh:

Year:  2014        PMID: 24284371     DOI: 10.1097/MEG.0b013e328363716e

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

Review 1.  Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others.

Authors:  Mecit Kantarci; Berhan Pirimoglu
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 2.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

3.  Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2.

Authors:  Wu Bi; Ji-Chang Xiao; Rui-Jie Liu; Liu-Ying Zhou; Sai Zhang; Mei Yang; Peng-Fei Zhang
Journal:  Invest New Drugs       Date:  2019-05-11       Impact factor: 3.850

Review 4.  C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications.

Authors:  Chiara Floridi; Alessandro Radaelli; Nadine Abi-Jaoudeh; Michael Grass; Micheal Grass; MingDe Lin; Ming De Lin; Melanie Chiaradia; Jean-Francois Geschwind; Hicham Kobeiter; Hishman Kobeiter; Ettore Squillaci; Geert Maleux; Andrea Giovagnoni; Luca Brunese; Bradford Wood; Gianpaolo Carrafiello; Antonio Rotondo
Journal:  Radiol Med       Date:  2014-07-11       Impact factor: 3.469

5.  C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads.

Authors:  Roland Syha; Gerd Grözinger; Ulrich Grosse; Michael Maurer; Lars Zender; Marius Horger; Konstantin Nikolaou; Dominik Ketelsen
Journal:  Cancer Imaging       Date:  2015-12-29       Impact factor: 3.909

6.  Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Min Lin; Man-Man Tian; Wei-Ping Zhang; Li Xu; Ping Jin
Journal:  Onco Targets Ther       Date:  2016-11-14       Impact factor: 4.147

Review 7.  State of the art in magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Natally Horvat; Serena Monti; Brunna Clemente Oliveira; Camila Carlos Tavares Rocha; Romina Grazia Giancipoli; Lorenzo Mannelli
Journal:  Radiol Oncol       Date:  2018-11-26       Impact factor: 2.991

Review 8.  Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.

Authors:  Shamar Young; Andrew J Taylor; Tina Sanghvi
Journal:  J Clin Transl Hepatol       Date:  2018-02-14

Review 9.  Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment.

Authors:  Marco Gatti; Cesare Maino; Fatemeh Darvizeh; Alessandro Serafini; Eleonora Tricarico; Alessia Guarneri; Riccardo Inchingolo; Davide Ippolito; Umberto Ricardi; Paolo Fonio; Riccardo Faletti
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

10.  C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial.

Authors:  Roland Syha; Sergios Gatidis; Gerd Grözinger; Ulrich Grosse; Michael Maurer; Lars Zender; Marius Horger; Konstantin Nikolaou; Dominik Ketelsen
Journal:  Cancer Imaging       Date:  2016-09-21       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.